Please login to the form below

Not currently logged in
Email:
Password:

Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month

Interim analysis clinical trials

Monoclonal antibody has neutralised SARS-CoV-2 virus in vitro

Seres’ microbiome-based therapy hits the mark in phase 3

Drug reduced C.difficile infection recurrence

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Eli Lilly new HQDetailed phase 3 results presented at the virtual World Conference on Lung Cancer

Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track

BiogenDrug could become first treatment to reduce clinical decline in Alzheimer's

Bristol-Myers Squibb’s revenues rise on Celgene acquisition

BMS buildingSales of immunotherapy Opdivo decreased due to COVID-19 impact

Tecentriq combo fails in advanced triple negative breast cancer

TecentriqTecentriq plus paclitaxel failed to improve progression-free survival

Biogen pays Denali $1bn upfront for Parkinson’s disease programme

Alzweb1Deal includes portfolio of small molecule LRRK2 inhibitors

Novartis builds its case for novel MS treatment ofatumumab

Novartis HQDetailed results from phase 3 studies published in NEJM

Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer

ALK inhibitor improved progression-free survival in first-line setting

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics